Annual Cash & Cash Equivalents
$106.01 M
+$27.00 M+34.17%
December 31, 2023
Summary
- As of February 20, 2025, CNTB annual cash & cash equivalents is $106.01 million, with the most recent change of +$27.00 million (+34.17%) on December 31, 2023.
- During the last 3 years, CNTB annual cash & cash equivalents has fallen by -$48.60 million (-31.43%).
- CNTB annual cash & cash equivalents is now -60.40% below its all-time high of $267.72 million, reached on December 31, 2021.
Performance
CNTB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$110.17 M
+$4.17 M+3.93%
June 30, 2024
Summary
- As of February 20, 2025, CNTB quarterly cash and cash equivalents is $110.17 million, with the most recent change of +$4.17 million (+3.93%) on June 30, 2024.
- Over the past year, CNTB quarterly cash and cash equivalents has stayed the same.
- CNTB quarterly cash and cash equivalents is now -64.83% below its all-time high of $313.23 million, reached on June 30, 2021.
Performance
CNTB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CNTB Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +34.2% | 0.0% |
| 3 y3 years | -31.4% | 0.0% |
| 5 y5 years | +140.1% | -28.7% |
CNTB Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -60.4% | +34.2% | -58.9% | +39.4% |
| 5 y | 5-year | -60.4% | +140.1% | -64.8% | +39.4% |
| alltime | all time | -60.4% | +140.1% | -64.8% | +39.4% |
Connect Biopharma Holdings Limited Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $110.17 M(+3.9%) |
| Dec 2023 | $106.01 M(+34.2%) | $106.01 M(+30.4%) |
| Jun 2023 | - | $81.29 M(+2.9%) |
| Dec 2022 | $79.01 M | $79.01 M(-44.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $141.57 M(-47.1%) |
| Dec 2021 | $267.72 M(+73.2%) | $267.72 M(-14.5%) |
| Jun 2021 | - | $313.23 M(+102.6%) |
| Dec 2020 | $154.60 M(+250.1%) | $154.60 M |
| Dec 2019 | $44.16 M | - |
FAQ
- What is Connect Biopharma Holdings Limited annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Connect Biopharma Holdings Limited?
- What is Connect Biopharma Holdings Limited annual cash & cash equivalents year-on-year change?
- What is Connect Biopharma Holdings Limited quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Connect Biopharma Holdings Limited?
- What is Connect Biopharma Holdings Limited quarterly cash and cash equivalents year-on-year change?
What is Connect Biopharma Holdings Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of CNTB is $106.01 M
What is the all time high annual cash & cash equivalents for Connect Biopharma Holdings Limited?
Connect Biopharma Holdings Limited all-time high annual cash & cash equivalents is $267.72 M
What is Connect Biopharma Holdings Limited annual cash & cash equivalents year-on-year change?
Over the past year, CNTB annual cash & cash equivalents has changed by +$27.00 M (+34.17%)
What is Connect Biopharma Holdings Limited quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CNTB is $110.17 M
What is the all time high quarterly cash and cash equivalents for Connect Biopharma Holdings Limited?
Connect Biopharma Holdings Limited all-time high quarterly cash and cash equivalents is $313.23 M
What is Connect Biopharma Holdings Limited quarterly cash and cash equivalents year-on-year change?
Over the past year, CNTB quarterly cash and cash equivalents has changed by $0.00 (0.00%)